0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Research Report 2026
Published Date: 2026-03-02
|
Report Code: QYRE-Auto-30M17957
Home | Market Reports
Global Ultrasound guided Non invasive Diagnostic of Liver Fibrosis Market Research Report 2024
BUY CHAPTERS

Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Research Report 2026

Code: QYRE-Auto-30M17957
Report
2026-03-02
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market

The global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Ultrasound-guided non-invasive diagnosis of liver fibrosis can simultaneously obtain two indicators, the degree of liver fibrosis and the quantitative fatty liver, for the quantitative detection of liver fibrosis and fatty liver. This technology is suitable for all people of medium body size, and can roughly determine the degree of liver fibrosis without liver biopsy.
The devices currently available in the medical community to assess liver fibrosis and liver stiffness include Fibroscan and Acoustic Radiation Force Impulse imaging (ARFI, Acoustic Radiation Force Impulse imaging), two commonly used ultrasound instruments, as well as magnetic resonance imaging with special software. Imaging instruments, etc. Among them, liver fiber scanner should be the most commonly used method in clinical examination at present.
This report delivers a comprehensive overview of the global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis. The Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis market comprehensively. Regional market sizes by Technology, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Technology, by Application, and by region.
Market Segmentation

Scope of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Report

Report Metric Details
Report Name Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market
Segment by Technology
  • Transient Elastography
  • Acoustic radiation force impulse (ARFI) Imaging
by Application
  • Hospitals
  • Imaging Centers
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Echosens, Hisky Med, Eieling Technology, Mindray
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Technology, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Technology, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market report?

Ans: The main players in the Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market are Echosens, Hisky Med, Eieling Technology, Mindray

What are the Application segmentation covered in the Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market report?

Ans: The Applications covered in the Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market report are Hospitals, Imaging Centers

1 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Overview
1.1 Product Definition
1.2 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis by Technology
1.2.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Value by Technology: 2025 vs 2032
1.2.2 Transient Elastography
1.2.3 Acoustic radiation force impulse (ARFI) Imaging
1.3 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis by Application
1.3.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Imaging Centers
1.4 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size Estimates and Forecasts
1.4.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue 2021–2032
1.4.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales 2021–2032
1.4.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Competition by Manufacturers
2.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Market Share by Manufacturers (2021–2026)
2.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis, Product Types and Applications
2.7 Global Key Manufacturers of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis, Date of Entry into the Industry
2.8 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Competitive Situation and Trends
2.8.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Players Market Share by Revenue
2.8.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Scenario by Region
3.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Region: 2021–2032
3.2.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Region: 2021–2026
3.2.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Region: 2027–2032
3.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Region: 2021–2032
3.3.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Region: 2021–2026
3.3.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Region: 2027–2032
3.4 North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Facts & Figures by Country
3.4.1 North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Country (2021–2032)
3.4.3 North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Facts & Figures by Country
3.5.1 Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Country (2021–2032)
3.5.3 Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Facts & Figures by Region
3.6.1 Asia Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Region (2021–2032)
3.6.3 Asia Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Facts & Figures by Country
3.7.1 Latin America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Country (2021–2032)
3.7.3 Latin America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Facts & Figures by Country
3.8.1 Middle East and Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Country (2021–2032)
3.8.3 Middle East and Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Technology
4.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Technology (2021–2032)
4.1.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Technology (2021–2026)
4.1.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Technology (2027–2032)
4.1.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Market Share by Technology (2021–2032)
4.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Technology (2021–2032)
4.2.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Technology (2021–2026)
4.2.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Technology (2027–2032)
4.2.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Market Share by Technology (2021–2032)
4.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Price by Technology (2021–2032)
5 Segment by Application
5.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Application (2021–2032)
5.1.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Application (2021–2026)
5.1.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Application (2027–2032)
5.1.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Market Share by Application (2021–2032)
5.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Application (2021–2032)
5.2.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Application (2021–2026)
5.2.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Application (2027–2032)
5.2.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Market Share by Application (2021–2032)
5.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Echosens
6.1.1 Echosens Company Information
6.1.2 Echosens Description and Business Overview
6.1.3 Echosens Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Echosens Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Product Portfolio
6.1.5 Echosens Recent Developments/Updates
6.2 Hisky Med
6.2.1 Hisky Med Company Information
6.2.2 Hisky Med Description and Business Overview
6.2.3 Hisky Med Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Hisky Med Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Product Portfolio
6.2.5 Hisky Med Recent Developments/Updates
6.3 Eieling Technology
6.3.1 Eieling Technology Company Information
6.3.2 Eieling Technology Description and Business Overview
6.3.3 Eieling Technology Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Eieling Technology Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Product Portfolio
6.3.5 Eieling Technology Recent Developments/Updates
6.4 Mindray
6.4.1 Mindray Company Information
6.4.2 Mindray Description and Business Overview
6.4.3 Mindray Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Mindray Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Product Portfolio
6.4.5 Mindray Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Industry Chain Analysis
7.2 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Production Mode & Process Analysis
7.4 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales and Marketing
7.4.1 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Channels
7.4.2 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Distributors
7.5 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Customer Analysis
8 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Dynamics
8.1 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Industry Trends
8.2 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Drivers
8.3 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Challenges
8.4 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Value by Technology (US$ Million), 2025 vs 2032
 Table 2. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales (Units) of Key Manufacturers (2021–2026)
 Table 5. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Average Price (K US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis, Product Types and Applications
 Table 12. Global Key Manufacturers of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Companies by Tier (Tier 1, Tier 2, Tier 3), based on Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Region (Units), 2021–2026
 Table 18. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Market Share by Region (2021–2026)
 Table 19. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Region (Units), 2027–2032
 Table 20. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Market Share by Region (2027–2032)
 Table 21. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Market Share by Region (2021–2026)
 Table 23. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Market Share by Region (2027–2032)
 Table 25. North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Country (Units), 2021–2026
 Table 27. North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Country (Units), 2027–2032
 Table 28. North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Country (Units), 2021–2026
 Table 32. Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Country (Units), 2027–2032
 Table 33. Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Region (Units), 2021–2026
 Table 37. Asia Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Region (Units), 2027–2032
 Table 38. Asia Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Country (Units), 2021–2026
 Table 42. Latin America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Country (Units), 2027–2032
 Table 43. Latin America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Country (Units), 2021–2026
 Table 47. Middle East and Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Country (Units), 2027–2032
 Table 48. Middle East and Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales (Units) by Technology (2021–2026)
 Table 51. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales (Units) by Technology (2027–2032)
 Table 52. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Market Share by Technology (2021–2026)
 Table 53. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Market Share by Technology (2027–2032)
 Table 54. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue (US$ Million) by Technology (2021–2026)
 Table 55. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue (US$ Million) by Technology (2027–2032)
 Table 56. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Market Share by Technology (2021–2026)
 Table 57. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Market Share by Technology (2027–2032)
 Table 58. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Price (K US$/Unit) by Technology (2021–2026)
 Table 59. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Price (K US$/Unit) by Technology (2027–2032)
 Table 60. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales (Units) by Application (2021–2026)
 Table 61. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales (Units) by Application (2027–2032)
 Table 62. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Market Share by Application (2021–2026)
 Table 63. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Market Share by Application (2027–2032)
 Table 64. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Market Share by Application (2021–2026)
 Table 67. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Market Share by Application (2027–2032)
 Table 68. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Price (K US$/Unit) by Application (2021–2026)
 Table 69. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Price (K US$/Unit) by Application (2027–2032)
 Table 70. Echosens Company Information
 Table 71. Echosens Description and Business Overview
 Table 72. Echosens Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 73. Echosens Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Product
 Table 74. Echosens Recent Developments/Updates
 Table 75. Hisky Med Company Information
 Table 76. Hisky Med Description and Business Overview
 Table 77. Hisky Med Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 78. Hisky Med Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Product
 Table 79. Hisky Med Recent Developments/Updates
 Table 80. Eieling Technology Company Information
 Table 81. Eieling Technology Description and Business Overview
 Table 82. Eieling Technology Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 83. Eieling Technology Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Product
 Table 84. Eieling Technology Recent Developments/Updates
 Table 85. Mindray Company Information
 Table 86. Mindray Description and Business Overview
 Table 87. Mindray Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 88. Mindray Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Product
 Table 89. Mindray Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Distributors List
 Table 93. Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Customers List
 Table 94. Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Trends
 Table 95. Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Drivers
 Table 96. Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Challenges
 Table 97. Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis
 Figure 2. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Value by Technology (US$ Million), 2021–2032
 Figure 3. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Share by Technology: 2025 & 2032
 Figure 4. Transient Elastography Product Picture
 Figure 5. Acoustic radiation force impulse (ARFI) Imaging Product Picture
 Figure 6. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Share by Application: 2025 & 2032
 Figure 8. Hospitals
 Figure 9. Imaging Centers
 Figure 10. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size (US$ Million), 2021–2032
 Figure 12. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales (Units), 2021–2032
 Figure 13. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Average Price (K US$/Unit), 2021–2032
 Figure 14. Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Report Years Considered
 Figure 15. Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Share by Manufacturers in 2025
 Figure 16. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Players: Market Share by Revenue in Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis in 2025
 Figure 18. Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Market Share by Country (2021–2032)
 Figure 21. North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Market Share by Country (2021–2032)
 Figure 22. United States Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Market Share by Country (2021–2032)
 Figure 25. Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Market Share by Region (2021–2032)
 Figure 33. China Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. China Taiwan Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Southeast Asia Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Latin America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Market Share by Country (2021–2032)
 Figure 41. Latin America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Market Share by Country (2021–2032)
 Figure 42. Mexico Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Brazil Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Argentina Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Colombia Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Middle East and Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Market Share by Country (2021–2032)
 Figure 47. Middle East and Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Market Share by Country (2021–2032)
 Figure 48. Turkey Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Saudi Arabia Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. UAE Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Global Sales Market Share of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis by Technology (2021–2032)
 Figure 52. Global Revenue Market Share of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis by Technology (2021–2032)
 Figure 53. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Price (K US$/Unit) by Technology (2021–2032)
 Figure 54. Global Sales Market Share of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis by Application (2021–2032)
 Figure 55. Global Revenue Market Share of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis by Application (2021–2032)
 Figure 56. Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Price (K US$/Unit) by Application (2021–2032)
 Figure 57. Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS